Iron saccharate (CAS 8047-67-4)
QUICK LINKS
Iron saccharate is a compound containing iron that finds wide application in scientific research. Its chelating nature gives it a ring-like structure with metal ions. In scientific settings, iron saccharate serves various purposes, such as in vitro and in vivo research, biochemical and physiological studies.In vitro applications involve its use as a reagent in biochemical assays and as a labeling agent in protein studies. In addition, iron saccharate can be utilized in in vivo applications, particularly in animal models of disease. It is hypothesized that the iron ions in the chelate complex interact with proteins and other molecules in the body to aid the transport of iron throughout the system. This interaction between iron ions and proteins is considered to be the primary mechanism by which iron saccharate exerts its effects.
Iron saccharate (CAS 8047-67-4) References
- Iron status and iron supplementation in peritoneal dialysis patients. | Vychytil, A. and Haag-Weber, M. 1999. Kidney Int Suppl. 69: S71-8. PMID: 10084290
- The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. | Fishbane, S. and Kowalski, EA. 2000. Semin Dial. 13: 381-4. PMID: 11130261
- Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. | Prakash, S., et al. 2001. Perit Dial Int. 21: 290-5. PMID: 11475345
- Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. | Michaud, L., et al. 2002. Clin Nutr. 21: 403-7. PMID: 12381338
- Prolonged administration over six hours of large doses of intravenous iron saccharate (500 mg) prevents severe adverse reactions in peritoneal dialysis patients. | Aggarwal, HK., et al. 2002. Perit Dial Int. 22: 636-7. PMID: 12455582
- [The iron letter--an update on the treatment of iron deficiency anemia]. | Schaefer, RM., et al. 2006. Praxis (Bern 1994). 95: 357-64. PMID: 16550709
- [Current recommendations for the treatment of iron deficiency anemia]. | Schaefer, RM., et al. 2007. Rev Med Suisse. 3: 874-80. PMID: 17514929
- Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. | Shaheen, FA., et al. 2002. Saudi J Kidney Dis Transpl. 13: 131-40. PMID: 17660651
- Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. | Al-Mueilo, SH. 2005. Saudi J Kidney Dis Transpl. 16: 146-53. PMID: 18202490
- Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. | Zolezzi, M. 2003. Saudi J Kidney Dis Transpl. 14: 129-33. PMID: 18209437
- Intravenous Iron Saccharate in Hemodialysis Patients Receiving r-HuEPO. | Al-Momen, AK., et al. 1994. Saudi J Kidney Dis Transpl. 5: 168-72. PMID: 18583828
- Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection. | Stefánsson, BV., et al. 2008. Free Radic Biol Med. 45: 1302-7. PMID: 18775775
- Effects of intravenous iron saccharate on improving severe anemia in rheumatoid arthritis patients. | Chen, WS., et al. 2012. Clin Rheumatol. 31: 469-77. PMID: 22037665
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Iron saccharate, 1 g | sc-492222 | 1 g | $147.00 |